Showing results (1281-1290 of 1,385) with videos related to

Sort By:
Pageof 139
Journal of Applied Crystallography|June 29, 2017
Processing two-dimensional X-ray diffraction and small-angle scattering data in <i>DAWN 2</i>J Filik, A W Ashton, P C Y Chang, et al.
ACS ES&T Water|August 8, 2023
Public Awareness of and Support for the Use of Wastewater for SARS-CoV-2 Monitoring: A Community Survey in Louisville, KentuckyRochelle H Holm, J Michael Brick, Alok R Amraotkar, et al.
Human Gene Therapy|April 3, 1998
Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vectorS L Hart, C V Arancibia-Cárcamo, M A Wolfert, et al.
European Journal of Immunology|April 28, 2012
IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulateDavid Bernardo, Sara Vallejo-Díez, Elizabeth R Mann, et al.
Ethnicity & Health|November 30, 2020
Perceptions of electronic cigarettes among ethno-culturally diverse Latino adults in four US urban centersElena L Navas-Nacher, Mayra L Estrella, Aida L Giachello, et al.
Bioconjugate Chemistry|February 21, 2009
Stabilized integrin-targeting ternary LPD (lipopolyplex) vectors for gene delivery designed to disassemble within the target cellM Firouz Mohd Mustapa, Stephanie M Grosse, Laila Kudsiova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 2, 2010
A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lungNatasha B Leighl, Luis E Raez, Benjamin Besse, et al.
Breast Cancer Research and Treatment|October 24, 2017
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trialGabe S Sonke, Lowell L Hart, Mario Campone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2016
Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid TumorsDaniel D Von Hoff, Monica M Mita, Ramesh K Ramanathan, et al.
JAMA Oncology|July 7, 2018
Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical TrialKaren A Autio, Robert Dreicer, Justine Anderson, et al.
Pageof 139